此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Effect of Type 2 Diabetes Genetic Risk Information on Health Behaviors and Outcomes (TDE)

2014年4月9日 更新者:Duke University
The primary objective of the study is to assess the clinical utility of a genetic test for Type 2 diabetes risk in combination with standardized risk assessment compared with standardized risk assessment alone, and to measure whether changes in perceived risk following genetic testing for Type 2 diabetes risk are correlated with behavior change and increased concern about risk for Type 2 diabetes.

研究概览

地位

完全的

条件

详细说明

One thousand outpatients will be enrolled over two years at two university-affiliated primary care clinics. Patients will be assigned to one of three study arms: those who want genetic testing for diabetes risk will be randomly assigned to either receive the testing in addition to the SRA (SRA+G) or to receive the SRA only (SRA-only). Those who do not wish to have genetic testing will receive the SRA only. All patients will be surveyed at baseline, immediately after going through the SRA (risk-counseling visit; 2-4 weeks after initial visit), at 3 months post risk counseling visit and at 12 months post risk counseling visit. BMI, waist circumference, fasting plasma glucose and insulin will be measured at baseline and 12 months. Surveys will allow us to track patients' emotional responses to diabetes risk information and changing perceptions of personal risk for Type 2 diabetes over time, and to see if these correlate with subsequent diet and exercise behaviors.

We will use a linear model to assess the effects of genetic testing among the three study groups, using HOmeostasis Model Assessment of Insulin Resistance (HOMA-IR) and weight loss as the primary outcomes. We will use generalized linear ordinal regression models to fit the ordinal survey outcomes of risk perceptions to the continuous HOMA-IR and weight outcome variables.

研究类型

介入性

注册 (实际的)

450

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • North Carolina
      • Durham、North Carolina、美国、27705
        • Duke Family Medicine at Pickens
      • Durham、North Carolina、美国、27705
        • Duke Health Center at Pickett Rd

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 80年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Are male or female outpatients
  • No self-reported history of diabetes
  • No self-reported history of prior genetic testing for diabetes
  • Not pregnant (self report)
  • Are ≥18 and <81 years of age
  • Scheduled to receive serum glucose test in participating clinic
  • Fasting at time of blood draw (no food or drink - except water - previous 8 hours: self report)
  • Able and willing to give legally effective consent
  • Able and willing to participate in patient questionnaires
  • Ambulatory

Exclusion Criteria:

  • Previously or currently taking medications for lowering glucose (i.e., exenatide, pramlintide, metformin, rosiglitazone, pioglitazone, or future diabetes drugs) based on self-report and/or prescreening
  • Self-report of current or prior diabetes diagnosis
  • Self-reported prior history of genetic testing for diabetes
  • Baseline serum glucose test result >125

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
有源比较器:SRA+genetic test
patients randomized to receive genetic test for type 2 diabetes risk will be followed and surveyed and will be counseled based on SAR and genetic risk for type 2 diabetes
patients interested in genetic testing will be randomly assigned to either get testing for type 2 diabetes or not. All arms with receive standardized risk asessements. This study is evaluating behavior after receipt of genetic risk information and different types of counseling.
无干预:SRA only
Patients randomized to not get genetic testing will be followed and surveyed and will be counseled based on SRA only
无干预:no testing control
Patients not interested in genetic testing will be followed and surveyed. Counseling will be based on SRA only

研究衡量的是什么?

主要结果指标

结果测量
大体时间
Percentage of weight loss
大体时间:12 months
12 months

次要结果测量

结果测量
大体时间
Change in perceptions of personal risk for Type 2 diabetes
大体时间:12 months
12 months
Change in HOmeostasis Model Assessment of Insulin Resistance (HOMA-IR)
大体时间:12 months
12 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

合作者

调查人员

  • 首席研究员:Geoffrey Ginsburg, Md, PhD、Institute for Genome Sciences and Policy, Duke University
  • 首席研究员:Alex Cho, MD、Institute for Genome Sciences and Policy, Duke University
  • 首席研究员:Scott Joy, MD、Duke University
  • 首席研究员:Susanne Haga, PhD、Institute for Genome Sciences and Policy, Duke University
  • 首席研究员:Isaac Lipkus, PhD、Institute for Genome Sciences and Policy, Duke University
  • 首席研究员:Gloria Trujillo, MD、Duke University
  • 首席研究员:Julianne O'Daniel, PhD、Institute for Genome Sciences and Policy, Duke University

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2009年4月1日

初级完成 (实际的)

2011年9月1日

研究完成 (实际的)

2013年6月1日

研究注册日期

首次提交

2009年2月22日

首先提交符合 QC 标准的

2009年2月22日

首次发布 (估计)

2009年2月24日

研究记录更新

最后更新发布 (估计)

2014年4月10日

上次提交的符合 QC 标准的更新

2014年4月9日

最后验证

2014年4月1日

更多信息

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅